EMAIL THIS PAGE TO A FRIEND

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case study.


PMID 23827936

Abstract

Tens of thousands of children are sick with multidrug-resistant forms of tuberculosis (MDR-TB), but there are limited child-friendly delivery systems for second-line medications. This case study presents the development of a granular dosing spoon pediatric delivery system for para-aminosalicylic acid. This product is the first of its kind for MDR-TB and could serve as a model for the development of other urgently needed pediatric delivery systems for second-line anti-tuberculosis drugs.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

09415
Sodium 4-aminosalicylate dihydrate, ≥97.0% (T)
C7H6NNaO3 · 2H2O